StockNews.AI
TMO
StockNews.AI
82 days

Thermo Fisher Scientific Launches New Spectral Flow Cytometer Offering Increased Speed, Versatility and Reliability to Labs

1. Thermo Fisher launched the Attune Xenith Flow Cytometer for enhanced cell analysis. 2. This device speeds up research workflows and offers higher data accuracy. 3. It features clog-resistant design and high-speed acoustic technology for reliability. 4. The system supports flexible applications in immunology and immuno-oncology research. 5. Thermo Fisher aims to improve scientific knowledge with innovative lab tools.

6m saved
Insight
Article

FAQ

Why Bullish?

The new cytometer addresses existing limitations in the market and enhances research capabilities, likely attracting more customers, similar to how past product innovations led to spiking sales for Thermo Fisher.

How important is it?

The introduction of an advanced flow cytometer can materially influence future sales trends and market position, reflecting overall growth potential as noted in previous product releases.

Why Long Term?

As research quality improves, demand for such innovations will expand over time, similar to trends seen in other biotechnology innovations that have reinforced revenue growth for leading firms.

Related Companies

ILMNBDXSGEN
-Researchers can obtain deeper insights from cells with more colors and faster time to results with minimal sample volume WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today launched the spectral-enabled Invitrogen™ Attune™ Xenith™ Flow Cytometer, allowing immunology and immuno-oncology researchers to automate and streamline workflows to obtain more detailed and accurate insights from critical cellular samples. By leveraging Thermo Fisher’s legacy core acoustic focusing technology, this new solution offers improved time to results for scientists researching cellular behaviors and mechanisms and discovering targeted therapies. It enables both spectral unmixing and conventional flow cytometry, allowing researchers to tackle a broader range of applications with greater flexibility and sensitivity. As the field of flow cytometry grows and research needs become more complex, scientists require access to even more data from cells which can help provide insights into how diseases, including cancer, manifest and progress in the body. Traditional cytometers frequently face issues with complex data analysis, non-intuitive interfaces and frequent clogs, which can slow down the research process and cause waste of often irreplaceable tissue samples. The Attune Xenith Flow Cytometer addresses these common problems with its user-friendly software and a multitude of innovative features: High-Speed Acoustic Technology: Accelerates sample analysis, significantly reducing processing times while maintaining exceptional sensitivity. Clog-Resistant Design: Reduces stoppages and sample waste, allowing labs to operate more reliably with minimal sample volume. Higher Parametric Analysis: Equipped with six lasers and 51 fluorescent detectors, enabling detailed and accurate insights from each sample. Longer Uptime: Designed for extended operation without needing fluid changes, maximizing lab productivity. Built-in cameras, automated maintenance and remote diagnostics help ensure ease of use for researchers of all experience levels. “We’re thrilled to have the opportunity to provide immunologists and other researchers with a solution that not only allows the rapid analysis of parameters, but one that will also speed up the discovery and translation of critical research findings,” said Trisha Dowling, vice president of flow and imaging technologies at Thermo Fisher Scientific. “The Invitrogen Attune Xenith Flow Cytometer can handle a higher volume of samples quickly and efficiently, allowing scientists to analyze cells with exceptional precision.” “The Attune Xenith flow cytometer is a robust and powerful instrument that allows our users to quickly set up assays in conventional or spectral mode with flexibility and the well-known reliability and high-speed acoustics of the Attune product line,” shared Dr. Juan J. Garcia Vallejo, MD, PhD, MBA, Associate Professor for Molecular Cell Biology & Immunology, and Scientific Director of the Microscopy and Cytometry Core Facility of the Amsterdam UMC, who uses the instrument in his lab. The Attune Xenith Flow Cytometer is the latest advancement in Thermo Fisher Scientific’s extensive portfolio of flow cytometry solutions, including the Attune CytPix and NxT instruments. Its introduction reinforces the company’s longstanding commitment to advancing scientific knowledge by offering innovative tools that enhance lab efficiency, data accuracy and overall research capabilities. To learn more about the Attune Xenith, please visit our website and register for the webinar on June 18. *For research use only. Not for use in diagnostic procedures. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com. © 2025 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified. More News From THERMO FISHER SCIENTIFIC

Related News